Anheuser-Busch InBev SA/NV (BUD) News Today

Anheuser-Busch InBev SA/NV (NYSE: BUD) is receiving mostly favorable analyst attention, although the stock has recently traded lower. The main positive catalysts are improving beer volumes, market-share gains and higher earnings expectations, while one minor estimate reduction provides a limited counterpoint.

• Positive Sentiment: AB InBev reported a return to volume growth in the second quarter, with beer volumes rising 1.1%. Zacks attributed the improvement to market-share gains, investment in megabrands and stronger emerging-market performance, suggesting that the company’s global recovery may be gaining momentum. AB InBev's Volumes Return to Growth: Is a Bigger Recovery Brewing?
• Positive Sentiment: Zacks Research raised its fiscal 2026 EPS estimate for BUD to $4.43 from $4.27, above the $4.37 consensus. It also increased its fiscal 2027 estimate to $4.88 from $4.81 and fiscal 2028 to $5.32 from $5.31, indicating improved expectations for medium-term earnings growth.
• Positive Sentiment: Several quarterly estimates were lifted, including Q3 2026 EPS to $1.14 from $1.13, Q1 2027 to $1.09 from $1.05, Q2 2027 to $1.26 from $1.22, Q1 2028 to $1.13 from $1.10 and Q2 2028 to $1.59 from $1.38. These revisions support the view that operating momentum could translate into stronger profitability.
• Positive Sentiment: Zacks identified Anheuser-Busch InBev as a highly ranked value stock and argued that its financial profile may appeal to value and growth investors. The assessment could provide additional support for investor interest, though it is based on a research-style ranking rather than a new corporate development. Anheuser-Busch InBev Is a Top-Ranked Value Stock: Should You Buy?
• Neutral Sentiment: Zacks lowered its Q3 2027 EPS estimate slightly to $1.26 from $1.27. The change is small and does not offset the broader upward revisions to annual and near-term forecasts.